Dec 17 (Reuters) - The International Monetary Fund's executive board will discuss a $20 billion program for Argentina on Wednesday during an informal session in Washington, Bloomberg News reported on ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

LEXINGTON, Ky. (LEX 18) — Lexington city leaders are discussing plans to implement an Aerial Public Safety Support Program that would enhance how emergency services respond to calls using drone ...

Ahead of Zohran Mamdani’s official debut as mayor on Jan. 1, businesses are assessing what child care assistance they already provide employees and are considering adding more incentives, especially ...

Mayor Eric Johnson speaks to media after a shooting occurred at the Dallas Immigration and Customs Enforcement office on Wednesday, Sept. 24, 2025, in Dallas. Angela Piazza / Staff Photographer ...

The Blount County Schools Board of Education will meet this Thursday evening, and the Bible is on the agenda. In an agenda item introduced by board chair Chris Pass, a program called “Bible Release ...

GREENVILLE, N.C. (WITN) - Medical debt is a burden that affects millions of North Carolinians. “How can I pay off medical debt?” Pitt County resident Marlyn Hemby says. “I don’t want to go back to the ...

MORNING HEADLINES | South Carolina lawmakers reportedly are looking to send a bill to the governor’s desk next year that would ban the sale or distribution to anyone under 21 of low-dose hemp-derived ...

Faculty members and Penn administrators sat down with The Daily Pennsylvanian to discuss the new pilot courses introduced by the College of Arts and Sciences for first-year students this fall and ...

FARGO, N.D. (Valley News Live) - The Fargo City Commission will discuss the suspended distribution of glass pipes for drug users at its meeting Monday evening. Commissioner Michelle Turnberg added ...

uniQure’s “game changing” data announced in September, which showed significant slowing of Huntington’s disease (HD) progression in patients treated with its gene therapy candidate AMT-130, may not be ...